152 related articles for article (PubMed ID: 32871501)
1. Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy.
Gaston TE; Allendorfer JB; Nair S; Bebin EM; Grayson LP; Martin RC; Szaflarski JP;
Epilepsy Behav; 2020 Nov; 112():107358. PubMed ID: 32871501
[TBL] [Abstract][Full Text] [Related]
2. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy.
Nenert R; Allendorfer JB; Bebin EM; Gaston TE; Grayson LE; Houston JT; Szaflarski JP
Epilepsy Behav; 2020 Nov; 112():107297. PubMed ID: 32745959
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.
Martin RC; Gaston TE; Thompson M; Ampah SB; Cutter G; Bebin EM; Szaflarski JP
Epilepsy Behav; 2019 Aug; 97():105-110. PubMed ID: 31220785
[TBL] [Abstract][Full Text] [Related]
5. Face-name association task reveals memory networks in patients with left and right hippocampal sclerosis.
Klamer S; Milian M; Erb M; Rona S; Lerche H; Ethofer T
Neuroimage Clin; 2017; 14():174-182. PubMed ID: 28180076
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.
Park YD; Linder DF; Pope J; Flamini JR; Moretz K; Diamond MP; Long SA
Epilepsy Behav; 2020 Nov; 112():107474. PubMed ID: 33181893
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.
Gaston TE; Ampah SB; Martina Bebin E; Grayson LP; Cutter GR; Hernando K; Szaflarski JP;
Epilepsy Behav; 2021 Apr; 117():107862. PubMed ID: 33667843
[TBL] [Abstract][Full Text] [Related]
8. The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy.
Sharma AA; Szaflarski JP
Epilepsy Behav; 2024 Feb; 151():109606. PubMed ID: 38199054
[TBL] [Abstract][Full Text] [Related]
9. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
O'Neill A; Wilson R; Blest-Hopley G; Annibale L; Colizzi M; Brammer M; Giampietro V; Bhattacharyya S
Psychol Med; 2021 Mar; 51(4):596-606. PubMed ID: 31994476
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy.
Sharma AA; Nenert R; Allendorfer JB; Gaston TE; Grayson LP; Hernando K; Szaflarski JP
Epilepsy Behav Rep; 2019; 12():100341. PubMed ID: 32322816
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal activations in mesial temporal lobe epilepsy due to hippocampal sclerosis- an observational study on intramural encoding-delayed recall paradigms using task-based memory fMRI.
Rajesh PG; Thomas B; Pammi VSC; Kesavadas C; Alexander A; Radhakrishnan A; Thomas SV; Menon RN
Epilepsy Res; 2018 Sep; 145():31-39. PubMed ID: 29859335
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
Gaston TE; Szaflarski M; Hansen B; Bebin EM; Szaflarski JP;
Epilepsy Behav; 2019 Jun; 95():10-17. PubMed ID: 31003195
[TBL] [Abstract][Full Text] [Related]
13. Working memory in schizotypal personality disorder: fMRI activation and deactivation differences.
Vu MA; Thermenos HW; Terry DP; Wolfe DJ; Voglmaier MM; Niznikiewicz MA; McCarley RW; Seidman LJ; Dickey CC
Schizophr Res; 2013 Dec; 151(1-3):113-23. PubMed ID: 24161536
[TBL] [Abstract][Full Text] [Related]
14. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
15. Memory response and neuroimaging correlates of a novel cognitive rehabilitation program for memory problems in epilepsy: A pilot study.
Gaston TE; Nair S; Allendorfer JB; Martin RC; Beattie JF; Szaflarski JP
Restor Neurol Neurosci; 2019; 37(5):457-468. PubMed ID: 31282442
[TBL] [Abstract][Full Text] [Related]
16. Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.
Szaflarski JP; Hernando K; Bebin EM; Gaston TE; Grayson LE; Ampah SB; Moreadith R
Epilepsy Behav; 2019 Jun; 95():131-136. PubMed ID: 31048098
[TBL] [Abstract][Full Text] [Related]
17. Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.
Thompson MD; Martin RC; Grayson LP; Ampah SB; Cutter G; Szaflarski JP; Bebin EM
Epilepsy Behav; 2020 Oct; 111():107299. PubMed ID: 32759071
[TBL] [Abstract][Full Text] [Related]
18. Stable signatures of schizophrenia in the cortical-subcortical-cerebellar network using fMRI of verbal working memory.
Matsuo K; Chen SH; Liu CM; Liu CC; Hwang TJ; Hsieh MH; Chien YL; Hwu HG; Tseng WY
Schizophr Res; 2013 Dec; 151(1-3):133-40. PubMed ID: 24262681
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the cerebellar cortex and nuclei in verbal and visuospatial working memory: a 7 T fMRI study.
Thürling M; Hautzel H; Küper M; Stefanescu MR; Maderwald S; Ladd ME; Timmann D
Neuroimage; 2012 Sep; 62(3):1537-50. PubMed ID: 22634219
[TBL] [Abstract][Full Text] [Related]
20. The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study.
Bloomfield MAP; Green SF; Hindocha C; Yamamori Y; Yim JLL; Jones APM; Walker HR; Tokarczuk P; Statton B; Howes OD; Curran HV; Freeman TP
J Psychopharmacol; 2020 Sep; 34(9):981-989. PubMed ID: 32762272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
